Last edition
News about "Oncology"
Innovent's DOVBLERON Secures Second NMPA Approval for ROS1-Positive NSCLC
China's National Medical Products Administration (NMPA) has approved the second New Drug Application (NDA) of DOVBLERON®, a next-generation ROS1 tyrosine kinase inhibitor (TKI).
Oncology | 03/01/2025 | By Abha
Flare Therapeutics Partners with Roche Accelerate Drug Discovery in Oncology
This partnership will leverage Flare Therapeutics' proteomic and mass spectrometry platform and expertise, powered by its proprietary library of electrophilic compounds, to discover novel small molecule drugs aimed at previously undrugged transcription factor targets in oncology.
Oncology | 14/11/2024 | By Aishwarya
Phanes PT217 Gets Orphan Drug Designation for Neuroendocrine Carcinoma
PT217 is a first-in-class bispecific antibody targeting delta-like ligand 3 (DLL3) and cluster of differentiation 47 (CD47) being developed for patients with NEC.
Oncology | 17/08/2024 | By Aishwarya
Maiva Pharma Raises INR 1,000 Crore from Fundraising
Maiva Pharma has secured INR 1,000 crore in primary and secondary funding from a fund managed by Morgan Stanley Private Equity Asia and India Life Sciences Fund – IV (ILSF – IV).
Oncology | 03/05/2024 | By Aishwarya | 206
Sygnature Discovery Appoints New Chief Scientific Officer
Sygnature Discovery has appointed Dr. David Witty as Chief Scientific Officer (CSO) to its leadership team.
Oncology | 24/04/2024 | By Aishwarya | 116
Aptamer Sciences Files IND Application for Phase 1 Clinical Trial of AST-201
Aptamer Sciences Inc. has filed for an Investigational New Drug (IND) application for the phase 1 clinical trial of AST-201 with the Korean Ministry of Food and Drug Safety
Oncology | 26/03/2024 | By Manvi | 191
PCI Pharma to expand operations at Welsh site
The manufacturing operations will be upgraded as part of the company’s push into targeted oncology therapies
Oncology | 12/08/2022 | By Sudeep Soparkar | 495
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy